These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16841665)

  • 21. [Effect of Shenqi Fuzheng injection combined with chemotherapy in treating advanced colorectal carcinoma].
    Liang QL; Pan DC; Xie JR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 May; 29(5):439-41. PubMed ID: 19673337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multi-center randomized clinical study on Shenqi-fuzheng injection combined with chemotherapy in the treatment for lung cancer].
    Lin HS; Li DR
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):931-4. PubMed ID: 18478934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden.
    Kimby E; Björkholm M; Gahrton G; Glimelius B; Hagberg H; Johansson B; Johansson H; Juliusson G; Järnmark M; Löfvenberg E
    Ann Oncol; 1994; 5 Suppl 2():67-71. PubMed ID: 7515649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales.
    Dewilde S; Woods B; Castaigne JG; Parker C; Dunlop W
    J Med Econ; 2014 Feb; 17(2):111-24. PubMed ID: 24308372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
    Rolski J; Koralewski P; Pawlicki M
    Wiad Lek; 1993 May; 46(9-10):356-9. PubMed ID: 8236992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).
    Uyl-de Groot CA; Hagenbeek A; Verdonck LF; Löwenberg B; Rutten FF
    Bone Marrow Transplant; 1995 Sep; 16(3):463-70. PubMed ID: 8535321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
    J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).
    Blayney DW; LeBlanc ML; Grogan T; Gaynor ER; Chapman RA; Spiridonidis CH; Taylor SA; Bearman SI; Miller TP; Fisher RI;
    J Clin Oncol; 2003 Jul; 21(13):2466-73. PubMed ID: 12829664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].
    Huang HQ; Jiang WQ; Wang W; Zhou ZM; Xia ZJ; Lin XB; Li YH; Xu RH; Zhang L; Xu GC; Sun XF; Liu DG; He YJ; Guan ZZ
    Ai Zheng; 2003 Apr; 22(4):389-92. PubMed ID: 12703995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
    Hou M; Li L; Qiu M; Yan X; Zhu J; Gou HF
    Ai Zheng; 2005 Apr; 24(4):461-4. PubMed ID: 15820070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis.
    Xu R; Lin L; Li Y; Li Y
    PLoS One; 2017; 12(9):e0185254. PubMed ID: 28953950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical observation on treatment of advanced gastric cancer by combined use of Shenqi Fuzheng injection, docetaxel, flurouracil and calcium folinate].
    Zhao JM; Wu AZ; Shi LR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):736-8. PubMed ID: 17879541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical study on treatment of mammary cancer by shenqi fuzheng injection in cooperation with chemotherapy.
    Bo Y; Li HS; Qi YC; Lu MY
    Chin J Integr Med; 2007 Mar; 13(1):37-40. PubMed ID: 17578316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systematic review and Meta-analysis of Shenqi Fuzheng injection combined with first-line chemotherapy for non-small cell lung cancer].
    Hao TT; Xie YM; Liao X; Wang J
    Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(20):4094-107. PubMed ID: 27062833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aidi injection combined with CHOP chemotherapy regimen in the treatment of malignant lymphoma: A meta-analysis based on randomized controlled trials.
    Wang X; Jin W; Fang B; Jiang J; Liu M; Lan Y; Qu Z; Ma G; Jiang Y; Liu Y; Zeng Y; Wang X
    J Cancer Res Ther; 2016 Oct; 12(Supplement):11-14. PubMed ID: 27721243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.